![Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome | BMC Gastroenterology | Full Text Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome | BMC Gastroenterology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12876-017-0605-x/MediaObjects/12876_2017_605_Fig4_HTML.gif)
Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome | BMC Gastroenterology | Full Text
![Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome | BMC Gastroenterology | Full Text Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome | BMC Gastroenterology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12876-017-0605-x/MediaObjects/12876_2017_605_Fig1_HTML.gif)
Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome | BMC Gastroenterology | Full Text
![PDF) Comparative Genomic and Functional Analysis of Lactobacillus casei and Lactobacillus rhamnosus Strains Marketed as Probiotics PDF) Comparative Genomic and Functional Analysis of Lactobacillus casei and Lactobacillus rhamnosus Strains Marketed as Probiotics](https://i1.rgstatic.net/publication/234124642_Comparative_Genomic_and_Functional_Analysis_of_Lactobacillus_casei_and_Lactobacillus_rhamnosus_Strains_Marketed_as_Probiotics/links/548fd6f20cf225bf66a80558/largepreview.png)
PDF) Comparative Genomic and Functional Analysis of Lactobacillus casei and Lactobacillus rhamnosus Strains Marketed as Probiotics
![The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study | World Journal of Urology The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study | World Journal of Urology](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00345-020-03580-7/MediaObjects/345_2020_3580_Fig1_HTML.png)
The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study | World Journal of Urology
![A Novel Rhamnose-Rich Hetero-exopolysaccharide Isolated from Lactobacillus paracasei DG Activates THP-1 Human Monocytic Cells | Applied and Environmental Microbiology A Novel Rhamnose-Rich Hetero-exopolysaccharide Isolated from Lactobacillus paracasei DG Activates THP-1 Human Monocytic Cells | Applied and Environmental Microbiology](https://journals.asm.org/cms/10.1128/AEM.02702-16/asset/8c3ea820-dcae-481d-98d7-c97a81614bda/assets/graphic/zam9991176330001.jpeg)
A Novel Rhamnose-Rich Hetero-exopolysaccharide Isolated from Lactobacillus paracasei DG Activates THP-1 Human Monocytic Cells | Applied and Environmental Microbiology
![Frontiers | Quantitative Recovery of Viable Lactobacillus paracasei CNCM I-1572 (L. casei DG®) After Gastrointestinal Passage in Healthy Adults Frontiers | Quantitative Recovery of Viable Lactobacillus paracasei CNCM I-1572 (L. casei DG®) After Gastrointestinal Passage in Healthy Adults](https://www.frontiersin.org/files/Articles/372902/fmicb-09-01720-HTML/image_m/fmicb-09-01720-g003.jpg)
Frontiers | Quantitative Recovery of Viable Lactobacillus paracasei CNCM I-1572 (L. casei DG®) After Gastrointestinal Passage in Healthy Adults
![JCM | Free Full-Text | Lactobacillus paracasei CNCM I 1572: A Promising Candidate for Management of Colonic Diverticular Disease JCM | Free Full-Text | Lactobacillus paracasei CNCM I 1572: A Promising Candidate for Management of Colonic Diverticular Disease](https://www.mdpi.com/jcm/jcm-11-01916/article_deploy/html/images/jcm-11-01916-g003.png)
JCM | Free Full-Text | Lactobacillus paracasei CNCM I 1572: A Promising Candidate for Management of Colonic Diverticular Disease
![In vitro and in vivo evidences for innate immune stimulators lactic acid bacterial starters isolated from fermented camel dairy products | Scientific Reports In vitro and in vivo evidences for innate immune stimulators lactic acid bacterial starters isolated from fermented camel dairy products | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-018-31006-3/MediaObjects/41598_2018_31006_Fig1_HTML.png)
In vitro and in vivo evidences for innate immune stimulators lactic acid bacterial starters isolated from fermented camel dairy products | Scientific Reports
![Microorganisms | Free Full-Text | Variability of Genetic Characters Associated with Probiotic Functions in Lacticaseibacillus Species Microorganisms | Free Full-Text | Variability of Genetic Characters Associated with Probiotic Functions in Lacticaseibacillus Species](https://pub.mdpi-res.com/microorganisms/microorganisms-10-01023/article_deploy/html/images/microorganisms-10-01023-g001a.png?1652421089)
Microorganisms | Free Full-Text | Variability of Genetic Characters Associated with Probiotic Functions in Lacticaseibacillus Species
![Rectal Administration of Lactobacillus casei DG Modifies Flora Composition and Toll-Like Receptor Expression in Colonic Mucosa of Patients with Mild Ulcerative Colitis | Digestive Diseases and Sciences Rectal Administration of Lactobacillus casei DG Modifies Flora Composition and Toll-Like Receptor Expression in Colonic Mucosa of Patients with Mild Ulcerative Colitis | Digestive Diseases and Sciences](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs10620-010-1384-1/MediaObjects/10620_2010_1384_Fig2_HTML.gif)
Rectal Administration of Lactobacillus casei DG Modifies Flora Composition and Toll-Like Receptor Expression in Colonic Mucosa of Patients with Mild Ulcerative Colitis | Digestive Diseases and Sciences
![PDF) Survival of L. casei DG® (Lactobacillus paracasei CNCMI1572) in the gastrointestinal tract of a healthy paediatric population PDF) Survival of L. casei DG® (Lactobacillus paracasei CNCMI1572) in the gastrointestinal tract of a healthy paediatric population](https://i1.rgstatic.net/publication/329278496_Survival_of_L_casei_DGR_Lactobacillus_paracasei_CNCMI1572_in_the_gastrointestinal_tract_of_a_healthy_paediatric_population/links/5fb7ca1092851c933f432f48/largepreview.png)
PDF) Survival of L. casei DG® (Lactobacillus paracasei CNCMI1572) in the gastrointestinal tract of a healthy paediatric population
![JCM | Free Full-Text | Lactobacillus paracasei CNCM I 1572: A Promising Candidate for Management of Colonic Diverticular Disease JCM | Free Full-Text | Lactobacillus paracasei CNCM I 1572: A Promising Candidate for Management of Colonic Diverticular Disease](https://www.mdpi.com/jcm/jcm-11-01916/article_deploy/html/images/jcm-11-01916-g001.png)
JCM | Free Full-Text | Lactobacillus paracasei CNCM I 1572: A Promising Candidate for Management of Colonic Diverticular Disease
![Effect of Lactobacillus paracasei CNCM I‐1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial - Cremon - 2018 - Effect of Lactobacillus paracasei CNCM I‐1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial - Cremon - 2018 -](https://onlinelibrary.wiley.com/cms/asset/5206294d-fb3e-47a6-b0f3-e7949d80b0f3/ueg2bf00173-fig-0002-m.jpg)
Effect of Lactobacillus paracasei CNCM I‐1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial - Cremon - 2018 -
![Rectal Administration of Lactobacillus casei DG Modifies Flora Composition and Toll-Like Receptor Expression in Colonic Mucosa of Patients with Mild Ulcerative Colitis | Digestive Diseases and Sciences Rectal Administration of Lactobacillus casei DG Modifies Flora Composition and Toll-Like Receptor Expression in Colonic Mucosa of Patients with Mild Ulcerative Colitis | Digestive Diseases and Sciences](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs10620-010-1384-1/MediaObjects/10620_2010_1384_Fig3_HTML.gif)
Rectal Administration of Lactobacillus casei DG Modifies Flora Composition and Toll-Like Receptor Expression in Colonic Mucosa of Patients with Mild Ulcerative Colitis | Digestive Diseases and Sciences
![PDF) Quantitative Recovery of Viable Lactobacillus paracasei CNCM I-1572 (L. casei DG®) After Gastrointestinal Passage in Healthy Adults PDF) Quantitative Recovery of Viable Lactobacillus paracasei CNCM I-1572 (L. casei DG®) After Gastrointestinal Passage in Healthy Adults](https://i1.rgstatic.net/publication/326777664_Quantitative_Recovery_of_Viable_Lactobacillus_paracasei_CNCM_I-1572_L_casei_DGR_After_Gastrointestinal_Passage_in_Healthy_Adults/links/5b6312cd458515298ce0a68c/largepreview.png)
PDF) Quantitative Recovery of Viable Lactobacillus paracasei CNCM I-1572 (L. casei DG®) After Gastrointestinal Passage in Healthy Adults
Comparative sequence analysis of a recA gene fragment brings new evidence for a change in the taxonomy of the Lactobacillus case
The Lactobacillus Casei Group: Exploitation for Food and Health-Related Applications | Frontiers Research Topic
![(PDF) Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: An ex-vivo organ culture model of post-infectious irritable bowel syndrome (PDF) Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: An ex-vivo organ culture model of post-infectious irritable bowel syndrome](https://i1.rgstatic.net/publication/316113280_Lactobacillus_casei_DG_and_its_postbiotic_reduce_the_inflammatory_mucosal_response_An_ex-vivo_organ_culture_model_of_post-infectious_irritable_bowel_syndrome/links/5fc24c58299bf104cf889f4a/largepreview.png)
(PDF) Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: An ex-vivo organ culture model of post-infectious irritable bowel syndrome
![Frontiers | Quantitative Recovery of Viable Lactobacillus paracasei CNCM I-1572 (L. casei DG®) After Gastrointestinal Passage in Healthy Adults Frontiers | Quantitative Recovery of Viable Lactobacillus paracasei CNCM I-1572 (L. casei DG®) After Gastrointestinal Passage in Healthy Adults](https://www.frontiersin.org/files/Articles/372902/fmicb-09-01720-HTML/image_m/fmicb-09-01720-g002.jpg)
Frontiers | Quantitative Recovery of Viable Lactobacillus paracasei CNCM I-1572 (L. casei DG®) After Gastrointestinal Passage in Healthy Adults
![Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome | BMC Gastroenterology | Full Text Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome | BMC Gastroenterology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12876-017-0605-x/MediaObjects/12876_2017_605_Fig2_HTML.gif)
Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome | BMC Gastroenterology | Full Text
SOFAR - ENTEROLACTIS® is the best ally to promote the balance of intestinal flora. The products in the range are mainly formulated with L. casei DG®, an exclusive probiotic strain, created and
![PDF) The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study PDF) The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study](https://i1.rgstatic.net/publication/348446334_The_use_of_Lactobacillus_casei_DGR_prevents_symptomatic_episodes_and_reduces_the_antibiotic_use_in_patients_affected_by_chronic_bacterial_prostatitis_results_from_a_phase_IV_study/links/5fffdc3992851c13fe0d7e21/largepreview.png)
PDF) The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study
![The Lactobacillus Casei Group: Exploitation for Food and Health-Related Applications | Frontiers Research Topic The Lactobacillus Casei Group: Exploitation for Food and Health-Related Applications | Frontiers Research Topic](https://www.frontiersin.org/files/MyHome%20Article%20Library/343048/343048_Thumb_400.jpg)
The Lactobacillus Casei Group: Exploitation for Food and Health-Related Applications | Frontiers Research Topic
![Inverigo, Italy - September 10, 2016: SOFAR ENTEROLACTIS Drinkable Lactobacillus Casei Nutritional Supplement In A Disposable Bottle Stock Photo, Picture and Royalty Free Image. Image 62870709. Inverigo, Italy - September 10, 2016: SOFAR ENTEROLACTIS Drinkable Lactobacillus Casei Nutritional Supplement In A Disposable Bottle Stock Photo, Picture and Royalty Free Image. Image 62870709.](https://previews.123rf.com/images/divgradcurl/divgradcurl1609/divgradcurl160900005/62870709-inverigo-italy-september-10-2016-sofar-enterolactis-drinkable-lactobacillus-casei-nutritional.jpg)
Inverigo, Italy - September 10, 2016: SOFAR ENTEROLACTIS Drinkable Lactobacillus Casei Nutritional Supplement In A Disposable Bottle Stock Photo, Picture and Royalty Free Image. Image 62870709.
![Survival of L. casei DG® (Lactobacillus paracasei CNCMI1572) in the gastrointestinal tract of a healthy paediatric population | European Journal of Nutrition Survival of L. casei DG® (Lactobacillus paracasei CNCMI1572) in the gastrointestinal tract of a healthy paediatric population | European Journal of Nutrition](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00394-018-1860-5/MediaObjects/394_2018_1860_Fig2_HTML.png)